Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 74051 - 74075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	MIR938	100126327	downregulated	Silver analog results in decreased expression of MIR938 mRNA	10p11.23	A24215
Silver	Approved Investigational	MIRLET7C	406885	downregulated	Silver analog results in decreased expression of MIRLET7C mRNA	21q21.1	A24215
Silver	Approved Investigational	MIRLET7C	406885	downregulated	Silver results in decreased expression of MIRLET7C mRNA	21q21.1	A24215
Silver	Approved Investigational	MIRLET7G	406890	downregulated	Silver analog results in decreased expression of MIRLET7G mRNA	3p21.2	A24215
Silver	Approved Investigational	MSX1	4487	upregulated	Silver results in increased expression of MSX1 mRNA	4p16.2	A24216
Silver	Approved Investigational	MT1A	4489	upregulated	Silver analog results in increased expression of MT1A mRNA	16q13	A24215
Silver	Approved Investigational	MT1A	4489	upregulated	Silver results in increased expression of MT1A mRNA	16q13	A24218 A24226
Silver	Approved Investigational	MT1B	4490	upregulated	Silver analog results in increased expression of MT1B mRNA	16q13	A24222
Silver	Approved Investigational	MT1E	4493	upregulated	Silver results in increased expression of MT1E mRNA	16q13	A24216
Silver	Approved Investigational	MT1F	4494	upregulated	Silver analog results in increased expression of MT1F mRNA	16q13	A24215 A24222
Silver	Approved Investigational	MT1F	4494	upregulated	Silver results in increased expression of MT1F mRNA	16q13	A24216
Silver	Approved Investigational	MT1G	4495	upregulated	Silver analog results in increased expression of MT1G mRNA	16q13	A24215
Silver	Approved Investigational	MT1H	4496	upregulated	Silver analog results in increased expression of MT1H mRNA	16q13	A24215 A24222
Silver	Approved Investigational	MT1H	4496	upregulated	Silver results in increased expression of MT1H mRNA	16q13	A24215 A24216
Silver	Approved Investigational	MT1M	4499	upregulated	Silver results in increased expression of MT1M mRNA	16q13	A24216
Silver	Approved Investigational	MT1X	4501	upregulated	Silver analog results in increased expression of MT1X mRNA	16q13	A24222
Silver	Approved Investigational	MT1X	4501	upregulated	Silver results in increased expression of MT1X mRNA	16q13	A24216
Silver	Approved Investigational	MT2A	4502	upregulated	Silver analog results in increased expression of MT2A mRNA	16q13	A24215 A24222
Silver	Approved Investigational	MT2A	4502	upregulated	Silver results in increased expression of MT2A mRNA	16q13	A24218 A24226 A24215
Silver	Approved Investigational	NETO1	81832	downregulated	Silver results in decreased expression of NETO1 mRNA	18q22.3	A24216
Silver	Approved Investigational	NFE2L2	4780	upregulated	Silver analog results in increased expression of NFE2L2 mRNA	2q31.2	A24227
Silver	Approved Investigational	NFE2L2	4780	upregulated	Silver results in increased expression of NFE2L2 mRNA	2q31.2	A24218
Silver	Approved Investigational	NFKB1	4790	upregulated	Silver results in increased expression of NFKB1 mRNA	4q24	A24217
Silver	Approved Investigational	NFKB2	4791	downregulated	Silver results in decreased expression of NFKB2 mRNA	10q24.32	A24217
Silver	Approved Investigational	NLGN4X	57502	downregulated	Silver results in decreased expression of NLGN4X mRNA	Xp22.32-p22.31	A24216

Displaying entries 74051 - 74075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability